Shares outstanding increased 14.8%
Shares outstanding changed +14.8% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +14.8% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Operating income changed -8.8% from the comparable as-filed period.
Research & development changed +10.5% from the comparable as-filed period.
Selling, general & administrative changed +7.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +10.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.